Merck (MRK) Shares Issued (2009 - 2026)

Merck (MRK) reported Shares Issued of $157.0 million for Q1 2026, up 726.32% year-over-year from $19.0 million in Q1 2025, and up 234.04% quarter-over-quarter from $47.0 million in Q4 2025.

Merck (MRK) Shares Issued (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Shares Issued data on file, last reported at $157.0 million in Q1 2026.

  • Shares Issued for Q1 2026 came in at $157.0 million, up 726.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $230.0 million (up 111.01% YoY), and the FY2025 annual result was $92.0 million, down 48.02% from the prior year.
  • Shares Issued improved to $157.0 million in Q1 2026 per MRK's latest filing, from $47.0 million in the prior quarter.
  • Over five years, Shares Issued peaked at $265.0 million in Q4 2022 and troughed at $5.0 million in Q3 2024.
  • A 5-year average of $55.0 million and a median of $19.0 million in 2025 frame the typical range for Shares Issued.
  • The sharpest annual moves came in 2023 and 2026: Shares Issued tumbled 97.74% in 2023, then jumped 726.32% in 2026.
  • A 5-year view of Shares Issued shows it stood at $265.0 million in 2022, then plunged by 97.74% to $6.0 million in 2023, then jumped by 100.0% to $12.0 million in 2024, then soared by 291.67% to $47.0 million in 2025, then jumped by 234.04% to $157.0 million in 2026.
  • Business Quant data shows MRK's Shares Issued at $157.0 million in Q1 2026, $47.0 million in Q4 2025, and $14.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 10.79 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 1.17 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 157.00 Mn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 166.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 157.00 Mn
Mar 31, 2026 157.00 Mn
Dec 31, 2025 47.00 Mn
Dec 31, 2025 47.00 Mn
Sep 30, 2025 14.00 Mn
Sep 30, 2025 14.00 Mn
Jun 30, 2025 12.00 Mn
Jun 30, 2025 12.00 Mn
Mar 31, 2025 19.00 Mn
Mar 31, 2025 19.00 Mn
Dec 31, 2024 12.00 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 5.00 Mn
Sep 30, 2024 5.00 Mn
Jun 30, 2024 73.00 Mn
Jun 30, 2024 73.00 Mn
Mar 31, 2024 87.00 Mn
Mar 31, 2024 87.00 Mn
Dec 31, 2023 6.00 Mn
Dec 31, 2023 6.00 Mn